Pelvic Organ Prolapse: Contemporary Surgical Options and Evidence-Based Management

Abstract

Background: Pelvic organ prolapse (POP) is the descent of the bladder, uterus, small bowel, or rectum into or through the vaginal canal following failure of pelvic floor connective tissue and muscular support. Symptomatic prolapse affects an estimated 3 to 6 percent of women, while some degree of descent is demonstrable on examination in nearly half of parous women. Although the condition is rarely life-threatening, its impact on physical activity, urinary and bowel function, body image, and sexual wellbeing is substantial, and the lifetime risk of undergoing surgery for prolapse or urinary incontinence approaches 20 percent. Objective: To compare the anatomical and functional outcomes, postoperative complications, recurrence rates, and patient satisfaction among women undergoing different surgical procedures for pelvic organ prolapse, and to identify factors associated with successful surgical outcomes. Methods: This was a prospective observational study conducted among women undergoing surgical management for pelvic organ prolapse. Clinical, demographic, surgical, and postoperative outcome data were collected and analyzed to compare the effectiveness, complications, recurrence rates, and patient satisfaction associated with different surgical approaches. Key Findings: Apical support is the structural determinant of durability, and failure to address apical descent is the leading cause of early recurrence. Sacrocolpopexy, performed increasingly by laparoscopic or robotic routes, offers the most durable apical correction at the cost of longer operative time and graft-related risks, with mesh exposure reported at approximately 2 to 10 percent. Vaginal native tissue suspensions, including uterosacral ligament suspension and sacrospinous ligament fixation, show equivalent outcomes to one another, with composite success declining to roughly 60 percent at five years. Obliterative colpocleisis achieves anatomic success above 95 percent with minimal morbidity in appropriately counselled women who do not desire penetrative intercourse. The 2019 FDA order withdrawing transvaginal mesh for prolapse repair from the United States market did not extend to sacrocolpopexy mesh or to midurethral slings, a distinction frequently misunderstood by patients and by non-specialist clinicians. Conclusion: There is no default operation for pelvic organ prolapse. Surgical selection should be driven by the compartment or compartments involved, apical integrity, sexual function goals, surgical history, anaesthetic risk, and the patient's own tolerance for recurrence versus graft-related risk. Because prolapse surgery is elective and quality-of-life driven, structured preoperative counselling using validated patient-reported outcome measures is as important to a successful result as the operative technique itself.